Sign in

CIK 0001520262

  • Large accelerated filer

Alkermes plc.

Sign in to watch
Ticker
ALKS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981007018
Phone
+353 17728000
Business address
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
Former names
ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$697,937
in 4 filings, $698K under 10b5-1 plans

Net −$697,937. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-06-14 Daglio David Angelo Jr. Director Grant or award · Non Qualified Stock Option (Right to Buy) +15,677 15,677
2021-06-14 Daglio David Angelo Jr. Director Grant or award · Restricted Stock Unit Award +7,585 7,585
2021-06-14 Cooke Shane Director Grant or award · Non Qualified Stock Option (Right to Buy) +15,677 15,677
2021-06-14 Cooke Shane Director Grant or award · Restricted Stock Unit Award +7,585 7,585
2021-06-14 ANSTICE DAVID W Director Grant or award · Non Qualified Stock Option (Right to Buy) +15,677 15,677
2021-06-14 ANSTICE DAVID W Director Grant or award · Restricted Stock Unit Award +7,585 7,585
2021-06-14 Alva Emily Peterson Director Grant or award · Non Qualified Stock Option (Right to Buy) +15,677 15,677
2021-06-14 Alva Emily Peterson Director Grant or award · Restricted Stock Unit Award +7,585 7,585
2021-06-10 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Exercise or conversion +13,500 $16.55 $223K 88,097
2021-06-10 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Sale −13,500 $25.00 $338K 74,597
2021-06-10 Gaffin David Joseph SVP, CLO, Alkermes, Inc. Exercise or conversion · Employee Stock Option (Right to Buy) −13,500 14,000
2021-06-10 DIXON WENDY L Director Exercise or conversion +25,000 $18.21 $455K 66,300
2021-06-10 DIXON WENDY L Director Sale −25,000 $25.00 $625K 41,300
2021-06-10 DIXON WENDY L Director Exercise or conversion · Non Qualified Stock Option (Right to Buy) −25,000 0
2021-06-09 Hopkinson Craig C. EVP R&D, Chief Medical Officer Sale −882 $24.60 $22K 0
2021-06-09 Alva Emily Peterson Director Grant or award · Restricted Stock Unit Award +532 532
2021-06-09 Alva Emily Peterson Director Grant or award · Non Qualified Stock Option (Right to Buy) +1,115 1,115
2021-06-09 Alva Emily Peterson Director Grant or award · Restricted Stock Unit Award +11,387 11,387
2021-06-09 Alva Emily Peterson Director Grant or award · Non Qualified Stock Option (Right to Buy) +22,759 22,759
2021-06-07 Hopkinson Craig C. EVP R&D, Chief Medical Officer Exercise or conversion +1,250 1,250

Page 61 of 75 · 1,492 trades